Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

Progression‐associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis

(2023) Jacqueline Fontugne et al.   JOURNAL OF PATHOLOGY

Do Patients Benefit from a Trial of Corticosteroids at the End of Life?

(2022) Sriram Yennurajalingam et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound

(2022) Iris E. Ertl et al.   EUROPEAN UROLOGY

High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas

(2022) Katherine C. Kurnit et al.   Gynecologic Oncology Reports

What's new in WHO fifth edition – urinary tract

(2022) Eva Compérat et al.   HISTOPATHOLOGY

Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery

(2022) Yeon Soo Kim et al.   European Urology Focus

Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens

(2022) Sumana Srivatsa et al.   Nature Communications

Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens

(2021) Raphaelle Servant et al.   JOURNAL OF PATHOLOGY

First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder

(2021) Johannes Eberhard et al.   Scientific Reports

Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung

(2021) Arthur Krause et al.   Translational Lung Cancer Research

Integrated analysis of multimodal single-cell data

(2021) Yuhan Hao et al.   CELL

Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?

(2021) Isabel Mayayo-Peralta et al.   ENDOCRINE-RELATED CANCER

The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma

(2021) Richard Cathomas et al.   EUROPEAN UROLOGY

RUNX1 marks a luminal castration resistant lineage established at the onset of prostate development

(2020) Renaud Mevel et al.   eLife

Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer

(2019) Charles C. Guo et al.   Cell Reports

MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices

(2019) Christopher S. McGinnis et al.   NATURE METHODS

Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer

(2019) Vera Genitsch et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Urothelial organoids originating from Cd49fhigh mouse stem cells display Notch-dependent differentiation capacity

(2019) Catarina P. Santos et al.   Nature Communications

What Is the Significance of Variant Histology in Urothelial Carcinoma?

(2019) Niyati Lobo et al.   European Urology Focus

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

(2018) Suk Hyung Lee et al.   CELL

Maftools: efficient and comprehensive analysis of somatic variants in cancer

(2018) Anand Mayakonda et al.   GENOME RESEARCH

The Role of Glucocorticoid Receptor Signaling in Bladder Cancer Progression

(2018) Hiroki Ide et al.   Cancers

Characteristics and clinical significance of histological variants of bladder cancer

(2017) Marco Moschini et al.   Nature Reviews Urology

Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition

(2016) Joseph Sanfrancesco et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Sarcomatoid Carcinoma of the Urinary Bladder

(2016) Midhun Malla et al.   Clinical Genitourinary Cancer

Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs

(2016) Marc Hafner et al.   NATURE METHODS

FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing

(2016) Ronglai Shen et al.   NUCLEIC ACIDS RESEARCH

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

(2015) Maria Vinci et al.   Jove-Journal of Visualized Experiments

Reduced Glucocorticoid Receptor Expression Predicts Bladder Tumor Recurrence and Progression

(2014) Hitoshi Ishiguro et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Trimmomatic: a flexible trimmer for Illumina sequence data

(2014) Anthony M. Bolger et al.   BIOINFORMATICS

Variation in Drug Sensitivity of Malignant Mesothelioma Cell Lines with Substantial Effects of Selenite and Bortezomib, Highlights Need for Individualized Therapy

(2013) Adam Szulkin et al.   PLoS One

STAR: ultrafast universal RNA-seq aligner

(2012) Alexander Dobin et al.   BIOINFORMATICS

An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

(2012) L. A. Byers et al.   CLINICAL CANCER RESEARCH

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff

(2012) Pablo Cingolani et al.   FLY

Contrary Regulation of Bladder Cancer Cell Proliferation and Invasion by Dexamethasone-Mediated Glucocorticoid Receptor Signals

(2012) Y. Zheng et al.   MOLECULAR CANCER THERAPEUTICS

Absolute quantification of somatic DNA alterations in human cancer

(2012) Scott L Carter et al.   NATURE BIOTECHNOLOGY

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-β1-induced epithelial-to-mesenchymal transition and cell migration

(2010) Liang Zhang et al.   FEBS LETTERS

Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications

(2009) Mahul B Amin   MODERN PATHOLOGY